3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
21
Other hematologic neoplasm
10
Plasma cell
4
Myeloid
4
Genitourinary
4
Dermatologic
2
Thoracic
1
Sarcoma
1
Other neoplasm
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Lung Neoplasms
3644
Carcinoma, Non-Small-Cell Lung
3585
Small Cell Lung Carcinoma
576
Breast Neoplasms
419
Neoplasms
299
Adenocarcinoma of Lung
249
Colorectal Neoplasms
222
Melanoma
201
Mesothelioma, Malignant
183
Pancreatic Neoplasms
179
Prostatic Neoplasms
178
Brain Neoplasms
178
Head and Neck Neoplasms
173
Neoplasm Metastasis
167
Ovarian Neoplasms
153
Esophageal Neoplasms
152
Mesothelioma
145
Colonic Neoplasms
140
Stomach Neoplasms
139
NSCLC
115
Pleural Effusion, Malignant
114
Carcinoma, Renal Cell
109
Urinary Bladder Neoplasms
105
Disease
96
Sarcoma
85
Uterine Cervical Neoplasms
82
Thymoma
79
Liver Neoplasms
77
Motor Activity
75
Squamous Cell Carcinoma of Head and Neck
72
Interventions
palbociclib
1
Rivaroxaban
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Immune System Diseases
×
Thoracic
×
Clear all
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled